Coverages and factors associated with influenza vaccination among subjects with chronic respiratory diseases in Spain

European Journal of Public Health

Volumn 18, Issue 2, 2008, Pages 173-177

  López De Andrés, Ana ^a   Carrasco Garrido, Pilar ^a   Hernández Barrera, Valentín ^a   De Miguel, Ángel Gil ^a   Jiménez García, Rodrigo ^a,b  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b Facultad de Ciencias de la Salud   (Spain)

Author keywords

Asthma; Chronic bronchitis; Chronic respiratory disease; Influenza; Survey; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; ASTHMA; CHILD; CHRONIC BRONCHITIS; CHRONIC RESPIRATORY TRACT DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FINANCE; HEALTH STATUS; HEALTH SURVEY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; LIFESTYLE; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPAIN;

ADULT; AGE FACTORS; CHILD; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; RESPIRATION DISORDERS; SOCIOECONOMIC FACTORS; SPAIN; VACCINATION;

EID: 40849106436     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckm093     Document Type: Article

References (53)

1. Ryan J, Zoellner Y, Gradl B, et al. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Vaccine 2006;24:6812-22.
2. Kroneman M, van Essen GA, John Paget W. Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine 2006;24:622-8.
3. Bueving HJ, Thomas S, Wouden JC. Is influenza vaccination in asthma helpful? Curr Opin Allergy Clin Immunol 2005;5:65-70.
4. Meier CR, Napalkov PN, Wegmuller Y, et al. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000;19:834-42.
5. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86.
6. Sobradillo V, Miravitlles M, Jimenez CA, et al. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation. Arch Bronconeumol 1999;35:159-66.
7. Basagaña X, Sunyer J, Zock J, et al. Incidence of asthma and its determinants among adults in Spain. Am J Respir Crit Care Med 2001;164:1133-7.
8. Ompad DC, Galea S, Vlahor D. Distribution of influenza vaccine to high-risk groups. Epidemiol Rev 2006;28:54-70.
9. Vu T, Farish S, Jenkins M, et al. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002;20:1831-6.
10. Nichol KL. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 2003;21:1769-75.
11. Wongsurakiat P, Maranetra KN, Wasi C, et al. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004;125:2011-20.
12. Puig-Barbera J, Marquez-Calderon S, Masoliver-Fores A, et al. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. J Epidemiol Community Health 1997;51:526-30.
13. van Essen GA, Palache AM, Forleo E, et al. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003;21:1780-5.
14. Jimenez-Garcia R, Mayo-Montero E, Hernández-Barrera V, et al. Evolution of anti-influenza vaccination coverage in Spain from 1993 to 2001. Vaccine 2005;23:2844-50.
15. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2005;54:1-36.
16. Esposito S, Marchisio P, Droghetti R, et al. Influenza vaccination coverage among children with high-risk medical conditions. Vaccine 2006;24:5251-5.
17. Kramarz P, DeStefano F, Gargiullo PM, et al. Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team. Vaccine 2000;18:2288-94.
18. Chung EK, Casey R, Pinto-Martin JA, et al. Routine and influenza vaccination rates in children with asthma. Ann Allergy Asthma Immunol 1998;80:318-22.
19. Sánchez Callejas A, Campins Martí M, Martínez Gómez X, et al. Vacunación antigripal en niños ingresados en un hospital de tercer nivel. Factores asociados a las coberturas. An Pediatr (Barc) 2006;65:331-6.
20. Ford ES, Mannino DM, Williams SG. Asthma and influenza vaccination: findings from the 1999-2001 National Health Interview Surveys. Chest 2003;124:783-9.
21. Ford ES, Williams SG, Mannino DM, et al. Influenza vaccination coverage among adults with asthma: findings from the 2000 behavioral risk factor surveillance system. Am J Med 2004;116:555-8.
22. Mayo Montero E, Hernández Barrera V, Carrasco Garrido P, et al. Influenza vaccination among persons with chronic respiratory diseases: coverage, related factors and time-trend, 1993-2001. Public Health 2007;121:113-21.
23. Janes GR, Blackman DK, Bolen JC, et al. Surveillance for use of preventive health-care services by older adults 1995-1997. MMWR CDC Surveill Summ 1999;48:51-88.
24. Centers for Disease Control and Prevention (CDC). Influenza and pneumococcal vaccination levels among persons aged > or = 65 years-United States, 2001. MMWR Morb Mortal Wkly Rep 2002;5:1019-24.
25. Instituto Nacional de Estadística. Spanish National Health Survey 2003. Available at: http://www.ine.es/en/metodologia/t15/t1530419_en.pdf (accessed on 15 February 2007).
26. Dombkowski KJ, Davis MM, Cohn LM, et al. Effect of missed opportunities on influenza vaccination rates among children with asthma. Arch Pediatr Adolesc Med 2006;160:966-71.
27. Vázquez-Fernández del Pozo S, Hernández-Barrera V, Carrasco-Garrido P, et al. Influenza vaccination coverage and related factors among Spanish children. J Infect 2007;54:483-9.
28. Woods C, Arcury T, Powers J, et al. Determinants of health care use by children in rural western North Carolina: results from the mountain accessibility project survey. Pediatrics 2003;112:143-52.
29. Feinberg E, Swartz K, Zaslavsky A, et al. Family income and the impact of children's health insurance program on reported need for health services and unmet health need. Pediatrics 2002;109:e29.
30. Impicciatore P, Bossetti C, Schiavio S, et al. Mothers and active partners in the prevention of childhood diseases: maternal factors related to immunization status of preschool children in Italy. Prev Med 2000;31:49-55.
31. Topuzoglu A, Ozaydin G, Cali S, et al. Assessment of sociodemographic factors and socioeconomic status affecting the coverage of compulsory and private immunization services in Istanbul, Turkey. Public Health 2005;119:862-9.
32. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years and persons aged 18-64 years with diabetes or asthma-United States, 2003. MMWR Morb Mortal Wkly Rep 2004;53:1007-12.
33. Egede LE, Zheng D. Racial/ethnic differences in influenza vaccination coverage in high-risk adults. Am J Public Health 2003;93:2074-8.
34. Jimenez-Garcia R, Arinez-Fernández MC, García-Carballo M, et al. Influenza vaccination coverage and related factors among Spanish patients with chronic obstructive pulmonary disease. Vaccine 2005;23:3679-86.
35. Jimenez-Garcia R, Mayo-Montero E, Hernández-Barrera V, et al. Influenza vaccination among diabetic adults: related factors and trend from 1993 to 2001 in Spain. Diabetes Care 2005;28:2031-3.
36. Phillips MM. Targeting diabetes preventive care programs: insights from the 2001 behavioral risk factor surveillance survey. Prev Chronic Dis 2004;1:A07.
37. Chapman GB, Coups EJ. Predictors of influenza vaccine acceptance among healthy adults. Prev Med 1999;29:249-62.
38. Costa Tadeo X, Navarro Aznarez G, Campos Abellana C, et al. The evaluation of noncompliance in an anti-influenza vaccination program. Aten Primaria 1991;8:544-6.
39. Nichol KL, Zimmerman R. Generalist and subspecialist physicians' knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients: a nationwide survey. Arch Intern Med 2001;22:2702-8.
40. Honkanen PO, Keistinen T, Kivela SL. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine 1997;15:317-20.
41. Centers for Disease Control and Prevention (CDC). Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services. MMWR Morb Mortal Wkly Rep 2005;54:1-11.
42. Hak E, Hermens RP, Hoes AW, et al. Effectiveness of a co-ordinated nationwide programme improve influenza immunisation rates in The Netherlands. Scand J Prim Health Care 2000;18:237-41.
43. Centers for Disease Control & Prevention (CDC). Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults: a report on recommendations of the Task Force on Community Preventive Services. MMWR Morb Mortal Wkly Rep 1999;48:1-16.
44. Landi F, Onder G, Carpenter I, et al. Prevalence predictors of influenza vaccination among frail, community-living elderly patients. An international observational study. Vaccine 2005;23:3896-901.
45. Hutchison BG. Measurement of influenza vaccination status of the elderly by mailed questionnaire: response rate, validity and cost. Can J Public Health 1989;80:271-5.
46. Mac Donald R, Baken L, Nelson A, et al. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999;16:173-7.
47. Zimmerman RK, Raymund M, Janosky JE, et al. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 2003;21:1486-91.
48. Instituto Nacional de Estadística. Spanish National Health Survey 2003. Details on the evaluation of non respondents. Available at: http://www.ine.es/daco/daco42/sanitarias/evaluacion.pdf (accessed on 15 February 2007).
49. Macroepidemiology of Influenza Vaccination (MIV) Study Group. The macro-epidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 2005;23:5133-43.
50. Singleton JA, Greby SM, Wooten KG, et al. Influenza, pneumococcal, and tetanus toxioid vaccination of adults-United States, 1993-7. Mor Mortal Wkly Rep CDC Surveill Summ 2000;49:39-62.
51. Pleis JR, Gentleman JF. Using the National Health Interview Survey: time trends in influenza vaccinations among targeted adults. Eff Clin Pract 2002;5:(3 Suppl), E3.
52. Nelson DE, Powell-Giner E, Town M, et al. A comparison of national estimates from the National health interview survey and the behavioral risk factor surveillance system. Am J Public Health 2003;93:1335-41.
53. Kamal KM, Madhavan SS, Amonkar MM. Determinants of adult influenza and pneumonia immunization rates. J Am Pharm Assoc (Wash DC) 2003;43:403-11.